Abstract
Renal imaging is an essential investigative tool and preliminary task for determining a suitable sanative option for the treatment of kidney cancer. In recent decades, with the increasing usage of abdominal imaging, there is an upsurge in the number of adrenal incidentalomas. Among these accidentally revealed lesions, most of them are complex that warrant immediate aggressive treatment planning due to their malignant potential. The guidelines given by the American Urological Association (AUA), American College of Radiology (ACR), and European Association of Urology (EAU) vary concerning the use of ideal preliminary imaging modality to investigate the patients with suspected flank pain, hematuria, or palpable mass in the abdomen. Initially, an effort has been made to discriminate cystic and solid renal lesions which are helpful in separating benign and malignant nature as different imaging patterns are observed on distinct imaging modalities for solid and cystic renal lesions. Various attempts have been made to improve the accuracy of cancer diagnosis by employing different imaging modalities. The primary aim of this article is to study the capabilities of different imaging techniques for detecting and differentiating solid and cystic lesions to facilitate treatment planning based on computed tomography (CT), ultrasonography (US), magnetic resonance imaging (MRI), positron emission tomography (PET), and optical coherence tomography (OCT). Further, the advantages, disadvantages, new advancements, and future scope of each of the imaging modality have also been highlighted so that one can make a correct choice of imaging technique for diagnosis of a specific type of lesion. Additionally, some recommendations have also been mentioned by listing the requirements for the perfect imaging modality.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.References
Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7–34
Kidney cancer statistics (2016) Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/kidney-cancer. Accessed 29 Dec 2016
GLOBOCAN (2018) v1.0, Cancer incidence and mortality worldwide: International Agency for Research on Cancer. http://globocan.iarc.fr. Accessed 24 Jan 2019
Kaur R, Juneja M (2016) A survey of different imaging modalities for renal cancer. Indian J Sci Technol 9(44):1–6
Kaur R, Juneja M (2018) Comparison of different renal imaging modalities: an overview. In Progress in intelligent computing techniques: theory, practice, and applications, pp 47–57
Fujii Y, Komai Y, Saito K, Iimura Y, Yonese J, Kawakami S et al (2008) Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology. 72(3):598–602
Milner MJ, Mcneil B, Alioto J, Proud K, Rubinas T, Picken M, Ilner J, Mcneil B, Alioto J et al (2006) Fat poor renal angiomyolipoma: patient, computerized tomography and histological findings. J Urol 176(3):905–909
Fujii Y, Ajima J, Oka K, Tosaka A, Takehara Y (1995) Benign renal tumors detected among healthy adults by abdominal ultrasonography. Eur Urol 27(2):124–127
Kutikov A, Fossett LK, Ramchandani P, Tomaszewski JE, Siegelman ES, Banner MP et al (2006) Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology. 68(4):737–740
Flum AS, Hamoui N, Said MA, Yang XJ, Casalino DD, McGuire BB et al (2016) Update on the diagnosis and management of renal angiomyolipoma. J Urol 195(4+):834–846
Chronopoulos PN, Kaisidis GN, Vaiopoulos CK, Perits DM, Varvarousis MN, Malioris AV et al (2016) Spontaneous rupture of a giant renal angiomyolipoma-Wunderlich’s syndrome: report of a case. Int J Surg Case Rep 19:140–143
Lane BR, Aydin H, Danforth TL, Zhou M, Remer EM, Novick AC et al (2008) Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol 180(3):836–843
Bosniak MA (1986) The current radiological approach to renal cysts. Radiology. 158(1):1–10
Israel GM, Bosniak MA (2005) An update of the Bosniak renal cyst classification system. Urology. 66(3):484–488
Donin NM, Mohan S, Pham H, Chandarana H, Doshi A, Deng FM et al (2015) Clinicopathologic outcomes of cystic renal cell carcinoma. Clin Genitourin Cancer 13(1):67–70
Bosniak MA (1993) Problems in the radiologic diagnosis of renal parenchymal tumors. Urol Clin North Am 20(2):217–230
Graumann O, Osther SS, Karstoft J, Hørlyck A, Osther PJ (2015) Bosniak classification system: inter-observer and intra-observer agreement among experienced uroradiologists. Acta Radiol 56(3):374–383
El-Mokadem I, Budak M, Pillai S, Lang S, Doull R, Goodman C et al (2014) Progression, interobserver agreement, and malignancy rate in complex renal cysts (≥ Bosniak category IIF). Urol Oncol 32:24–e21
Hindman NM, Hecht EM, Bosniak MA (2014) Follow-up for Bosniak category 2F cystic renal lesions. Radiology. 272(3):757–766
O’malley RL, Godoy G, Hecht EM, Stifelman MD, Taneja SS (2009) Bosniak category IIF designation and surgery for complex renal cysts. J Urol 182(3):1091–1095
Perez-Ordonez B, Hamed G, Campbell S, Erlandson RA, Russo P, Gaudin PB et al (1997) Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol 21(8):871–883
Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z (2006) 2004 WHO classification of the renal tumors of the adults. Eur Urol 49(5):798–805
Oxley JD, Sullivan J, Mitchelmore A, Gillatt DA (2007) Metastatic renal oncocytoma. J Clin Pathol 60(6):720–722
Hartman DS, Choyke PL, Hartman MS (2004) From the RSNA refresher courses: a practical approach to the cystic renal mass. Radiographics 24(suppl_1):S101–S115
Hes O, Michal M, Šíma R, Vaněček T, Brunelli M, Martignoni G et al (2008) Renal oncocytoma with and without intravascular extension into the branches of renal vein have the same morphological, immunohistochemical, and genetic features. Virchows Arch 452(2):285–293
Bhatt S, MacLennan G, Dogra V (2007) Renal pseudotumors. AJR Am J Roentgenol 188(5):1380–1387
Chuang CK, Lai MK, Chang PL, Huang MH, Chu SH, Wu CJ et al (1992) Xanthogranulomatous pyelonephritis: experience in 36 cases. J Urol 147(2):333–336
Osca JM, Peiro MJ, Rodrigo M, Martinez-Jabaloyas JM, Jimenez-Cruz JF (1997) Focal xanthogranulomatous pyelonephritis: partial nephrectomy as definitive treatment. Eur Urol 32(3):375–379
Craig WD, Wagner BJ, Travis MD (2008) Pyelonephritis: radiologic-pathologic review. Radiographics. 28(1):255–276
Gudbjartsson T, Hardarson S, Petursdottir V, Thoroddsen A, Magnusson J, Einarsson GV (2005) Renal oncocytoma: a clinicopathological analysis of 45 consecutive cases. BJU Int 96(9):1275–1279
Warshauer DM, McCarthy SM, Street L, Bookbinder MJ, Glickman MG, Richter J et al (1988) Detection of renal masses: sensitivities and specificities of excretory urography/linear tomography, US, and CT. Radiology. 169(2):363–365
Kang SK, Chandarana H (2012) Contemporary imaging of the renal mass. Urol Clin North Am. 39(2):161–170
Kaur R, Juneja M, Mandal AK (2018) Computer-aided diagnosis of renal lesions in CT images: a comprehensive survey and future prospects. Comput Electr Eng 22
Kaur R, Juneja M (2018) A survey of kidney segmentation techniques in CT images. Current Medical Imaging Reviews. 14(2):238–250
Haliloglu AH, Gulpinar O, Ozden E, Beduk Y (2011) Urinary ultrasonography in screening incidental renal cell carcinoma: is it obligatory? Int Urol Nephrol 43(3):687–690
Heilbrun ME, Remer EM, Casalino DD, Beland MD, Bishoff JT, Blaufox MD et al (2014) ACR Appropriateness Criteria® - indeterminate renal mass. J Am Coll Radiol 12(4):333–341
Vikram R, Beland MD, Blaufox MD, Moreno CC, Gore JL, Harvin HJ et al (2016) ACR appropriateness criteria renal cell carcinoma staging. J Am Coll Radiol 13(5):518–525
O’Connor SD, Silverman SG, Ip IK, Maehara CK, Khorasani R (2013) Simple cyst–appearing renal masses at unenhanced CT: can they be presumed to be benign? Radiology. 269(3):793–800
Lane BR, Campbell SC, Remer EM, Fergany AF, Williams SB, Novick AC et al (2008) Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney: clinical, radiographic, and pathologic characteristics. Urology. 71(6):1142–1148
Pooler BD, Pickhardt PJ, O’Connor SD, Bruce RJ, Patel SR, Nakada SY (2012) Renal cell carcinoma: attenuation values on unenhanced CT. Am J Roentgenol 198(5):1115–1120
Jonisch AI, Rubinowitz AN, Mutalik PG, Israel GM (2007) Can high-attenuation renal cysts be differentiated from renal cell carcinoma at unenhanced CT? Radiology. 243(2):445–450
Silverman SG, Mortele KJ, Tuncali K, Jinzaki M, Cibas ES (2007) Hyperattenuating renal masses: etiologies, pathogenesis, and imaging evaluation. Radiographics. 27(4):1131–1143
Curry NS, Chung CJ, Gordon B (1994) Unilateral renal cystic disease in an adult. Abdom Imaging 19(4):366–368
Slywotzky CM, Bosniak MA (2001) Localized cystic disease of the kidney. Am J Roentgenol 176(4):843–849
Cho KJ, Thornbury JR, Bernstein J, Heidelberger KP, Walter JF (1979) Localized cystic disease of the kidney: angiographic-pathologic correlation. Am J Roentgenol 132(6):891–895
Katabathina VS, Kota G, Dasyam AK, Shanbhogue AK, Prasad SR (2010) Adult renal cystic disease: a genetic, biological, and developmental primer. Radiographics. 30(6):1509–1523
Wood CG, Stromberg LJ, Harmath CB, Horowitz JM, Feng C, Hammond NA et al (2015) CT and MR imaging for evaluation of cystic renal lesions and diseases. Radiographics. 35(1):125–141
Chow WH, Dong LM, Devesa SS (2010) Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7(5):245
Hartman DS, Davis CJ, Johns T, Goldman SM (1986) Cystic renal cell carcinoma. Urology. 28(2):145–153
Schieda N, Vakili M, Dilauro M, Hodgdon T, Flood TA, Shabana WM (2015) Solid renal cell carcinoma measuring water attenuation (− 10 to 20 HU) on unenhanced CT. Am J Roentgenol 205(6):1215–1221
Eble JN, Sauter G, Epstein JI, Sesterhenn IA (2004) Pathology and genetics of tumors of the urinary system and male genital organs. In: World Health Organ. Classif. Tumors. IARC Press, Lyon
Hindman NM, Bosniak MA, Rosenkrantz AB, Lee-Felker S, Melamed J (2012) Multilocular cystic renal cell carcinoma: comparison of imaging and pathologic findings. Am J Roentgenol 198(1):W20–W26
Eble JN, Bonsib SM (1998) Extensively cystic renal neoplasms: cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma, and cystic hamartoma of renal pelvis. Semin Diagn Pathol 15(1):2–20
Aubert S, Zini L, Delomez J, Biserte J, Lemaitre L, Leroy X (2005) Cystic renal cell carcinomas in adults. Is preoperative recognition of multilocular cystic renal cell carcinoma possible? J Urol 174(6):2115–2119
Smith AD, Remer EM, Cox KL, Lieber ML, Allen BC, Shah SN et al (2012) Bosniak category IIF and III cystic renal lesions: outcomes and associations. Radiology. 262(1):152–160
Couvidat C, Eiss D, Verkarre V, Merran S, Corréas JM, Méjean A et al (2014) Renal papillary carcinoma: CT and MRI features. Diagn Interv Imaging 95(11):1055–1063
Egbert ND, Caoili EM, Cohan RH, Davenport MS, Francis IR, Kunju LP et al (2013) Differentiation of papillary renal cell carcinoma subtypes on CT and MRI. Am J Roentgenol 201(2):347–355
Amin MB, MacLennan GT, Gupta R, Grignon D, Paraf F, Vieillefond A et al (2009) Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol 33(3):384–392
Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM (2016) The 2016 WHO classification of tumors of the urinary system and male genital organs—part A: renal, penile, and testicular tumors. Eur Urol 70(1):93–105
Moch H (2010) Cystic renal tumors: new entities and novel concepts. Adv Anat Pathol 17(3):209–214
Cornelis F, Helenon O, Correas JM, Lemaitre L, Andre M, Meuwly JY et al (2016) Tubulocystic renal cell carcinoma: a new radiological entity. Eur Radiol 26(4):1108–1115
Honda Y, Goto K, Nakamura Y, Terada H, Sentani K, Yasui W et al (2017) Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classification. Abdom Radiol 42(7):1850–1856
Jamis-Dow CA, Choyke PL, Jennings SB, Linehan WM, Thakore KN, Walther MM (1996) Small (< or = 3-cm) renal masses: detection with CT versus US and pathologic correlation. Radiology. 198(3):785–788
Desser TS, Jeffrey RB (2001) Tissue harmonic imaging techniques: physical principles and clinical applications. Semin Ultrasound CT MR 22(1):1–10
Schmidt T, Hohl C, Haage P, Blaum M, Honnef D, Weiβ C et al (2003) Diagnostic accuracy of phase-inversion tissue harmonic imaging versus fundamental B-mode sonography in the evaluation of focal lesions of the kidney. Am J Roentgenol 180(6):1639–1647
Siemer S, Uder M, Humke U, Lindenmeier T, Moll V, Rüdenauer E et al (2000) Value of ultrasound in early diagnosis of renal cell carcinoma. Urologe A 39(2):149–153
Zagoria RJ (2000) Imaging of small renal masses: a medical success story. Am J Roentgenol 175(4):945–955
Jinzaki M, Ohkuma K, Tanimoto A, Mukai M, Hiramatsu K, Murai M, Hata J (1998) Small solid renal lesions: usefulness of power Doppler US. Radiology. 209(2):543–550
Setola SV, Catalano O, Sandomenico F, Siani A (2007) Contrastenhanced sonography of the kidney. Abdom Imaging 32(1):21–28
Jakobsen J (1996) Echo-enhancing agents in the renal tract. Clin Radiol 51:40–43
Tamai H, Takiguchi Y, Oka M, Shingaki N, Enomoto S, Shiraki T, Furuta M, Inoue I, Iguchi M, Yanaoka K, Arii K, Shimizu Y, Nakata H, Shinka T, Sanke T, Ichinose M (2005) Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors. J Ultrasound Med 24(12):1635–1640
Barr RG, Peterson C, Hindi A (2014) Evaluation of indeterminate renal masses with contrast-enhanced US: a diagnostic performance study. Radiology. 271(1):133–142
Kazmierski B, Deurdulian C, Tchelepi H, Grant EG (2017) Applications of contrast-enhanced ultrasound in the kidney. Abdom Radiol (NY)
Chen L, Wang L, Diao X et al (2015) The diagnostic value of contrast-enhanced ultrasound in differentiating small renal carcinoma and angiomyolipoma. Biosci Trends 9:252–258
Mueller-Peltzer K, Negrao de Figueiredo G, Graf T, Rübenthaler J, Clevert DA (2019) Papillary renal cell carcinoma in contrast-enhanced ultrasound (CEUS)–a diagnostic performance study. Clin Hemorheol Microcirc 1(Preprint):1–6
Rübenthaler J, de Figueiredo GN, Mueller-Peltzer K, Clevert DA (2018) Evaluation of renal lesions using contrast-enhanced ultrasound (CEUS); a 10-year retrospective European single-centre analysis. Eur Radiol 28(11):4542–4549
Dai WB, Yu B, Diao XH, Cao H, Chen L, Chen Y, Zhan J (2019) Renal masses: evaluation with contrast-enhanced ultrasound, with a special focus on the pseudocapsule sign. Ultrasound Med Biol 45(8):1924–1932
Mu J, Mao Y, Li F, Xin X, Zhang S (2019) Superb microvascular imaging is a rational choice for accurate Bosniak classification of renal cystic masses. Br J Radiol 92(xxxx):20181038
Hindi A, Peterson C, Barr RG (2013) Artifacts in diagnostic ultrasound. Rep Med Imaging 6:29–48
Catalano C, Fraioli F, Laghi A, Napoli A, Pediconi F, Danti M et al (2003) High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma. Am J Roentgenol 180(5):1271–1277
Bosniak MA (1991) The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. Radiology. 179(2):307–317
Silverman SG, Lee BY, Seltzer SE, Bloom DA, Corless CL, Adams DF (1994) Small (< or = 3 cm) renal masses: correlation of spiral CT features and pathologic findings. Am J Roentgenol 163(3):597–605
Mileto A, Nelson RC, Paulson EK, Marin D (2015) Dual-energy MDCT for imaging the renal mass. Am J Roentgenol 204(6):W640–W647
Prasad SR, Dalrymple NC, Surabhi VR (2008) Cross-sectional imaging evaluation of renal masses. Radiol Clin N Am 46(1):95–111
Johnson PT, Horton KM, Fishman EK (2010) How not to miss or mischaracterize a renal cell carcinoma: protocols, pearls, and pitfalls. Am J Roentgenol 194(4):W307–W315
Israel GM, Bosniak MA (2005) How I do it: evaluating renal masses. Radiology. 236(2):441–450
Israel GM, Bosniak MA (2008) Pitfalls in renal mass evaluation and how to avoid them. Radiographics. 28(5):1325–1338
Yuh BI, Cohan RH, Francis IR, Korobkin M, Ellis JH (2000) Comparison of nephrographic with excretory phase helical computed tomography for detecting and characterizing renal masses. Can Assoc Radiol J 51(3):170
Shirkhoda A (1991) Diagnostic pitfalls in abdominal CT. Radiographics. 11(6):969–1002
Willatt JM, Hussain HK, Chong S, Kappil M, Azar SF, Liu PS et al (2014) MR imaging in the characterization of small renal masses. Abdom Imaging 39(4):761–769
Bae KT, Heiken JP, Siegel CL, Bennett HF (2000) Renal cysts: is attenuation artifactually increased on contrast-enhanced CT images? Radiology. 216(3):792–796
Schieda N, Avruch L, Flood TA (2014) Small (< 1 cm) incidental echogenic renal cortical nodules: chemical shift MRI outperforms CT for confirmatory diagnosis of angiomyolipoma (AML). Insights Imaging 5(3):295–299
Cohan RH, Sherman LS, Korobkin M, Bass JC, Francis IR (1995) Renal masses: assessment of corticomedullary-phase and nephrographic-phase CT scans. Radiology. 196(2):445–451
Johnson PT, Horton KM, Fishman EK (2010) Optimizing detectability of renal pathology with MDCT: protocols, pearls, and pitfalls. Am J Roentgenol 194(4):1001–1012
Birnbaum BA, Jacobs JE, Langlotz CP, Ramchandani P (1999) Assessment of a bolus-tracking technique in helical renal CT to optimize nephrographic phase imaging. Radiology. 211(1):87–94
Willemink MJ, Persson M, Pourmorteza A, Pelc NJ, Fleischmann D (2018 4) Photon-counting CT: technical principles and clinical prospects. Radiology. 289(2):293–312
Goo HW, Goo JM (2017) Dual-energy CT: new horizon in medical imaging. Korean J Radiol 18(4):555–569
Marin D, Davis D, Choudhury KR, Patel B, Gupta RT, Mileto A, Nelson RC (2017) Characterization of small focal renal lesions: diagnostic accuracy with single-phase contrastenhanced dual-energy CT with material attenuation analysis compared with conventional attenuation measurements. Radiology. 284(3):737–747
Deniffel D, Boutelier T, Labani A, Ohana M, Pfeiffer D, Roy C (2018) Computed tomography perfusion measurements in renal lesions obtained by bayesian estimation, advanced singular-value decomposition deconvolution, maximum slope, and Patlak models: intermodel agreement and diagnostic accuracy of tumor classification. Investig Radiol 53(8):477–485
Chen C, Kang Q, Xu B, Shi Z, Guo H, Wei Q, Lu Y, Wu X (2018) Fat poor angiomyolipoma differentiation from renal cell carcinoma at 320-slice dynamic volume CT perfusion. Abdom Radiol 43(5):1223–1230
Kim SH, Kim CS, Kim MJ et al (2016) Differentiation of clear cell renal cell carcinoma from other subtypes and fat-poor angiomyolipoma by use of quantitative enhancement measurement during three-phase MDCT. AJR Am J Roentgenol 206:W21–W28
Paño B, Macías N, Salvador R, Torres F, Buñesch L, Sebastià C, Nicolau C (2016) Usefulness of MDCT to differentiate between renal cell carcinoma and oncocytoma: development of a predictive model. Am J Roentgenol 206(4):764–774
Marin D, Davis D, Roy Choudhury K, Patel B, Gupta RT, Mileto A, Nelson RC (2017) Characterization of small focal renal lesions: diagnostic accuracy with single-phase contrast-enhanced dual-energy CT with material attenuation analysis compared with conventional attenuation measurements. Radiology. 284(3):737–747
Schieda N, Lim RS, Krishna S, McInnes MD, Flood TA, Thornhill RE (2018) Diagnostic accuracy of unenhanced CT analysis to differentiate low-grade from high-grade chromophobe renal cell carcinoma. Am J Roentgenol 210(5):1079–1087
Salameh JP, McInnes MD, McGrath TA, Salameh G, Schieda N (2019) Diagnostic accuracy of dual-energy CT for evaluation of renal masses: systematic review and meta-analysis. Am J Roentgenol 212(4):W100–W105
Pourvaziri A, Parakh A, Mojtahed A, Ramesh AK, Sahani D (2019) Diagnostic performance of dual-energy CT and subtraction CT for renal lesion detection and characterization. Eur Radiol 27:1–2
Pedrosa I, Alsop DC, Rofsky NM (2009) Magnetic resonance imaging as a biomarker in renal cell carcinoma. Cancer. 115(S10):2334–2345
Vendrami CL, Villavicencio CP, DeJulio TJ, Chatterjee A, Casalino DD, Horowitz JM, Oberlin DT, Yang GY, Nikolaidis P, Miller FH (2017) Differentiation of solid renal tumors with multiparametric MR imaging. Radiographics 37(7):2026–2042
Nazarian S, Hansford R, Rahsepar AA, Weltin V, McVeigh D, Ipek EG, Kwan A, Berger RD, Calkins H, Lardo AC, Kraut MA, Kamel IR, Zimmerman SL, Halperin HR (2017) Safety of magnetic resonance imaging in patients with cardiac devices. N Engl J Med 377(26):2555–2564
Lassel EA, Rao R, Schwenke C, Schoenberg SO, Michaely HJ (2014) Diffusion-weighted imaging of focal renal lesions: a meta-analysis. Eur Radiol 24(1):241–249
Hecht EM, Israel GM, Krinsky GA, Hahn WY, Kim DC, Belitskaya-Levy I et al (2004) Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology. 232(2):373–378
Holland AE, Goldfarb JW, Edelman RR (1998) Diaphragmatic and cardiac motion during suspended breathing: preliminary experience and implications for breath-hold MR imaging. Radiology. 209(2):483–489
Feng Q, Fang W, Sun XP, Sun SH, Zhang RM, Ma ZJ (2017) Renal clear cell carcinoma: diffusion tensor imaging diagnostic accuracy and correlations with clinical and histopathological factors. Clin Radiol 72(7):560–564
Van Baalen S, Froeling M, Asselman M, Klazen C, Jeltes C, Van Dijk L, Vroling B, Dik P, Ten Haken B (2018) Mono, bi-and tri-exponential diffusion MRI modelling for renal solid masses and comparison with histopathological findings. Cancer Imaging 18(1):44
van Oostenbrugge TJ, Fütterer JJ, Mulders PF (2018) Diagnostic imaging for solid renal tumors: a pictorial review. Kidney Cancer 1(Preprint):1–5
Kim BR, Song JS, Choi EJ, Hwang SB, Hwang HP (2018 Jun 1) Diffusion-weighted imaging of upper abdominal organs acquired with multiple b-value combinations: value of normalization using spleen as the reference organ. Korean J Radiol 19(3):389–396
Goyal A, Sharma R, Bhalla AS, Gamanagatti S, Seth A (2018) Comparison of MDCT, MRI and MRI with diffusion-weighted imaging in evaluation of focal renal lesions: the defender, challenger, and winner! Indian J Radiol Imaging 28(1):27
Nery F, Gordon I, Thomas DL (2018) Non-invasive renal perfusion imaging using arterial spin labeling MRI: challenges and opportunities. Diagnostics (Basel) 8(1)
De Leon AD, Kapur P, Pedrosa I (2019) Radiomics in kidney Cancer: MR imaging. Magn Reson Imaging Clin 27(1):1–3
Hötker AM, Mazaheri Y, Wibmer A, Karlo CA, Zheng J, Moskowitz CS, Tickoo SK, Russo P, Hricak H, Akin O (2017) Differentiation of clear cell renal cell carcinoma from other renal cortical tumors by use of a quantitative multiparametric MRI approach. Am J Roentgenol 208(3):W85–W91
Young JR, Coy H, Kim HJ, Douek M, Lo P, Pantuck AJ, Raman SS (2017) Performance of relative enhancement on multiphasic MRI for the differentiation of clear cell renal cell carcinoma (RCC) from papillary and chromophobe RCC subtypes and oncocytoma. Am J Roentgenol 208(4):812–819
Chiarello MA, Mali RD, Kang SK (2018) Diagnostic accuracy of MRI for detection of papillary renal cell carcinoma: a systematic review and meta-analysis. Am J Roentgenol 211(4):812–821
Akın IB, Altay C, Güler E, Çamlıdağ İ, Harman M, Danacı M, Tuna B, Yörükoğlu K, Seçil M (2019) Discrimination of oncocytoma and chromophobe renal cell carcinoma using MRI. Diagn Interv Radiol 25(1):5
Hain SF, Maisey MN (2003) Positron emission tomography for urological tumors. BJU Int 92(2):159–164
Kang DE, White RL Jr, Zuger JH, Sasser HC, Teigland CM (2004) Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J Urol 171(5):1806–1809
Schiepers C (2006) PET and PET/CT in kidney cancer. In: Imaging of Kidney Cancer. Springer, Berlin, pp 89–101
Bolton DM, Wong P, Lawrentschuk N (2007) Renal cell carcinoma: imaging and therapy. Curr Opin Urol 17(5):337–340
Garg G, Juneja M (2018) A survey of prostate segmentation techniques in different imaging modalities. Curr Med Imaging Rev 14(1):19–46
Garg G, Juneja M (2018) A survey of denoising techniques for multi-parametric prostate MRI. Multimed Tools Appl:1–34
Hu S, Zhang J, Cheng C, Liu Q, Sun G, Zuo C (2014) The role of 18 F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis. Abdom Imaging 39(6):1221–1227
Campbell SPTA, Javadi MS, Karlsson M, Solnes LB, Axelsson R, Allaf ME, Gorin MA, Rowe SP (2017) 99mTc-Sestamibi SPECT/CT for the characterization of renal masses: a pictorial guide. Br J Radiol
Jones KM, Solnes LB, Rowe SP, Gorin MA, Sheikhbahaei S, Fung G, Frey EC, Allaf ME, Du Y, Javadi MS (2017) Use of quantitative SPECT/CT reconstruction in 99mTc-sestamibi imaging of patients with renal masses. Ann Nucl Med
Alongi P, Picchio M, Zattoni F, Spallino M, Gianolli L, Saladini G, Evangelista L (2016) Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT. Eur J Nucl Med Mol Imaging 43(3):464–473
Nakanishi Y, Kitajima K, Yamada Y, Hashimoto T, Suzuki T, Go S, Kanematsu A, Nojima M, Yamakado K, Yamamoto S (2018) Diagnostic performance of 11 C-choline PET/CT and FDG PET/CT for staging and restaging of renal cell cancer. Ann Nucl Med 32(10):658–668
Johnson DC, Vukina J, Smith AB, Meyer AM, Wheeler SB, Kuo TM et al (2015) Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate. J Urol 193(1):30–35
Jain M, Robinson B, Salamoon B, Thouvenin O, Boccara C, Mukherjee S (2015) Rapid evaluation of fresh ex vivo kidney tissue with full-field optical coherence tomography. J Pathol Inf 6:53
van Manen L, Dijkstra J, Boccara C, Benoit E, Vahrmeijer AL, Gora MJ, Mieog JS (2018) The clinical usefulness of optical coherence tomography during cancer interventions. J Cancer Res Clin Oncol 144(10):1967–1990
Freund JE, Buijs M, Savci-Heijink CD, de Bruin DM, de la Rosette JJ, van Leeuwen TG, Laguna MP (2019) Optical coherence tomography in urologic oncology: a comprehensive review. SN Compr Clin Med 1(2):67–84
Lee HC, Zhou C, Cohen DW, Mondelblatt AE, Wang Y, Aguirre AD, Shen D, Sheikine Y, Fujimoto JG, Connolly JL (2012) Integrated optical coherence tomography and optical coherence microscopy imaging of ex vivo human renal tissues. J Urol 187(2):691–699
Buijs M, Wagstaff PG, de Bruin DM, Zondervan PJ, Savci-Heijink CD, van Delden OM, van Leeuwen TG, van Moorselaar RJ, de la Rosette JJ, Pes MP (2017) An in-vivo prospective study of the diagnostic yield and accuracy of optical biopsy compared with conventional renal mass biopsy for the diagnosis of renal cell carcinoma: the interim analysis. Eur Urol Focus 24
Auer T, Heidegger I, De Zordo T, Junker D, Jaschke W, Steinkohl F, Aigner F (2019) Fusion imaging of contrast-enhanced ultrasound with CT or MRI for kidney lesions. In Vivo 33(1):203–208
Brinker DA, Amin MB, de Peralta-Venturina M, Reuter V, Chan DY, Epstein JI (2000) Extensively necrotic cystic renal cell carcinoma: a clinicopathologic study with comparison to other cystic and necrotic renal cancers. Am J Surg Pathol 24(7):988–995
Katabathina VS, Shiao J, Flaherty E, Prasad SR (2016) Cross-sectional imaging of renal masses: image interpretation–related potential pitfalls and possible solutions. In: Seminars in roentgenology, vol 51(1). Elsevier, Amsterdam, pp 40–48
Kaur R, Juneja M, Mandal AK (2018) A hybrid edge-based technique for segmentation of renal lesions in CT images. Multimed Tools Appl:1–21
Correas JM, Claudon M, Tranquart F, Hélénon O (2006) The kidney: imaging with microbubble contrast agents. Ultrasound Q 22(1):53–66
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kaur, R., Juneja, M. & Mandal, A.K. An overview of non-invasive imaging modalities for diagnosis of solid and cystic renal lesions. Med Biol Eng Comput 58, 1–24 (2020). https://doi.org/10.1007/s11517-019-02049-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11517-019-02049-z